Article Information
- Received August 6, 2004
- Revision received October 17, 2004
- Accepted October 18, 2004
- First published December 1, 2004.
- Version of record published December 1, 2004.
Author Information
- 1Department of Psychiatry and Behavioral Sciences, University of Texas Medical Branch, Galveston, Texas 77555-0431, 2Laboratory of Clinical Science, National Institute of Mental Health-National Institutes of Health (NIH), and 3Section on Behavioral Science and Genetics, National Institute on Alcohol Abuse and Alcoholism-NIH, Bethesda, Maryland 20892, and 4Department of Pharmacology, Loyola University Chicago, Maywood, Illinois 60153
Author contributions
Disclosures
- Received August 6, 2004.
- Revision received October 17, 2004.
- Accepted October 18, 2004.
This work was supported in part by a National Alliance for Research on Schizophrenia and Depression Young Investigator Award to Q.L. and United States Public Health Service Grant NS34153 to L.D.V.d.K. We thank Dr. Bert Vogelstein of the Howard Hughes Medical Institute and The Sidney Kimmel Comprehensive Cancer Center and The Johns Hopkins University Medical Institutions for kindly providing adenoviral vectors. We also thank Drs. Tong-Chuan He and Jayaprakash D. Karkera for their excellent technical advice in the generation of recombinant adenovirus. We dedicate this manuscript to the memory of Dr. Louis D. Van de Kar, who passed away recently, for his contribution to neuroscience.
Correspondence should be addressed to Dr. Qian Li, Department of Psychiatry and Behavioral Sciences, University Texas of Medical Branch, 5.232 Mary Moody Northen Pavilion, 300 University Boulevard, Galveston, TX 77555-0431. E-mail: qili{at}utmb.edu.
Copyright © 2004 Society for Neuroscience 0270-6474/04/2410868-10$15.00/0
↵† Deceased, September 4, 2004.
